14.
PTBD/PTGBD, Biliary stent (Shunsuke Sugawara, MD)
Percutaneous transhepatic biliary drainage (PTBD) [1-3]
Shunsuke Sugawara, MD
Department of Diagnostic Radiology, National Cancer Center Hospital, Japan
Endoscopic drainage plays main role in biliary drainage and it is firstly indicated for
acute cholangitis. PTBD is indicated for patients whose endoscopic drainage through
the papilla of Vater failed or endoscopic approach is difficult due to anatomical issues
(e.g. post-surgical reconstructed gastrointestinal tract).
Ultrasound is mainly used for image guidance in PTBD, but CT and fluoroscopy are
also available. To puncture the intrahepatic bile duct, 21gauge needle is preferably used
to decrease risk of bleeding and critical organ injury. The intrahepatic bile duct in the
lateral segment or right lobe is targeted and external drainage tube is placed with
Seldinger technique. The PTBD tube is more stable in the lateral segment than that in
the right lobe because respiratory movement of the liver is smaller in the lateral
segment, and dislodgement of PTBD tube in the right lobe can more frequently occur
than lateral segment.
PTBD for nondilated bile duct is also feasible and the success rate is 70-100%
according to previous literatures. Parallel technique is used in PTBD for nondilated bile
duct. Intrahepatic bile duct runs on the lateral side of the portal vein in segment 6. In
parallel technique, 21gauge needle is advanced parallel to P6, and the needle is slowly
pulled back with gentle injection of contrast medium under fluoroscopic observation.
The bile duct is visualized when the tip of the needle is placed in the bile duct. After
visualization of B6, guidewire is inserted or the visualized B6 is punctured under
fluoroscopic guidance.
Complications of PTBD are pain, dislodgement or obstruction of PTBD tube,
infection (sepsis), biloma, biliary peritonitis, pleural effusion, pneumothorax, arterial
injury and others. In general, hepatic vein or portal vein injury does not cause severe
hemorrhagic complication.
Percutaneous transhepatic gallbladder drainage (PTGBD)[4, 5]
PTGBD is a well-established and standard treatment for acute cholecystitis.
PTGBD is indicated for surgically high-risk patients who cannot tolerate
straightforward cholecystectomy. In PTGBD, gallbladder is punctured under ultrasound
guidance with 18gauge needle and 6-10F drainage catheter is placed over the guidewire.
Gallbladder must be punctured through the gallbladder bed to prevent biliary
peritonitis caused by bile leakage. Percutaneous transhepatic gallbladder aspiration
(PTGBA) is an alternative percutaneous treatment, but it can be unsuccessful because
of replacement of bile with dense biliary sludge or pus. Complication of PTGBD is
minimum, but pain, bleeding, pleuritis, and sepsis can occur.
14. PTBD/PTGBD, Biliary stent (Shunsuke Sugawara, MD)
Biliary stent [6-10]
1. Concept of biliary stent
The purpose of biliary stenting is to reproduce normal bile juice flow with
expansion of biliary stricture and to relieve patients from restrictions caused by
drainage tubes. Biliary stenting is commonly used for patients with malignant biliary
stricture in palliative care setting. Retrograde endoscopic access via papilla of Vater is
widely performed for biliary stenting, especially for simple stricture of the common
bile duct (CBD). However, percutaneous access is required for complicated cases such
as multiple biliary strictures in hilum or postoperative cases with
choledocho-/hepaticojejunostomy.
2. Indications of biliary stent
(1) Unresectable malignant biliary stricture*
(2) Removal of PTBD tube is clinically meaningful
(3) No stricture in duodenum and lower intestine
(4) No uncontrollable coagulopathy
*In case of benign stenosis, metallic stent placement is not allowed except a
retrievable or biodegradable stent.
3. Procedures of biliary stent (Steps and Tips)
3-1. Simple stenosis
Step 1: PTBD (Percutaneous transhepatic biliary drainage)
The PTBD route with acute angle such as B2 and B7 access should not be used to
avoid technical difficulties in subsequent catheter manipulations.
Step 2: Drainage and contrast injection
Decompression of dilated bile duct is important to visualize the exact anatomy of
biliary system and the details of stricture site. We should keep in mind that contrast
injection with high pressure can cause septic shock.
Step 3: Insertion of an angiographic sheath (Figure 1)
Using an angiographic sheath is very useful to keep the route between skin
puncture point and biliary system, and to perform repeated injection of contrast.
Step 4: Crossing of stricture
A seeking catheter (multipurpose type) (4-6Fr) and a hydrophilic guidewire are the
key combination to success. The technical tip is not only pushing and pulling but also
rotating.
Step 5: Contrast injection into the lower biliary system and intestine (Figure 2).
In this process, the length and feature of the stricture must be evaluated, and the
function of papilla of Vater / duodenum / lower intestine must also be observed. The
actual length of stricture should be measured using a guidewire or a catheter.
Step 6: Exchange of guidewire (from hydrophilic to non-hydrophilic one)
14. PTBD/PTGBD, Biliary stent (Shunsuke Sugawara, MD)
Seeking catheter is advanced into the duodenum in order to perform exchange of
guidewire. To avoid accidental removal of guidewire, guidewire should be exchanged to a
stiff and non-hydrophilic coated one. A stiff guidewire also provides stability during
stent deployment.
Step 7: Taking reference images with contrast
The reference images acquired should be in the same direction as the image used
during stent deployment.
Step 8: Selection of stent (bare / covered, length and diameter).
Generally, covered stents have longer patency rate. However, bigger access route
and longer landing zone are needed to insert covered stents. The decision should be
made with deep considerations including technical factors, invasiveness and also the
patient’s life expectancy etc.
Step 9: Insertion of the stent delivery system beyond the stricture (Figure 4)
Delivery system is advanced beyond the stricture over the guidewire. When the
stricture is very narrow and tight, predilatation with a balloon catheter (6-8mm in
diameter) can be performed.
Step 10: Decision on point for stent deployment
The point for stent deployment must be decided with careful consideration about
foreshortening of the stent, especially when woven stents are used.
Step 11: Stent deployment (Figure 5)
The most important technical issue is to keep the key marker of stent at the same
point on by using real-time fluoroscopy during stent deployment.
Step 12: Removal of the stent delivery system
Contrast is injected via the angiographic sheath and position of stent is confirmed
if it is placed at the appropriate position. After that, the angiographic sheath is
removed.
Step 13: Insertion of a drainage tube (safety tube) and removal of guidewire
During processes between step 4 and step 13, the guidewire must be kept in
position. Safety tube should be placed proximal to the stent.
Step 14: Removal of safety tube
Safety tube is generally removed a few days after stent placement. Safety tube
should be clamped for a few days and it should be checked that the general condition
and laboratory data are stable. Just before the removal of safety tube, flow of
contrast to the duodenum is evaluated.
3-2. Complicated stenosis (Bismuth type III/IV)
Step 1: Technique of multiple stents placement
The crucial point of decision is “Which branches should be preserved, and which
branches should be sacrificed”. Volume of each segment and patency of portal veins are
assessed in deciding the technique of stent placement.
14. PTBD/PTGBD, Biliary stent (Shunsuke Sugawara, MD)
Step 2-10: (Same as Step 2-10 in simple stenosis)
Step 11: Insertion of multiple stent delivery systems (Figure 7)
All stent delivery systems must be set up at the appropriate positions before
deploying any stent especially when stents are placed side-by-side (parallel
formation).
Step 12: Stent deployment with parallel formation (Figure 8)
There are other techniques of multiple stents placement such as Y-formation and
T-formation. Parallel formation is much easier to perform re-intervention.
Step 13: Insertion of drainage tubes (safety tube) (Figure 9)
When the procedures were well performed with bare stents, placing one safety
tube is enough.
Step 14: Removal of the safety tube
Removal of the safety tube must be performed after confirmation of good flow of
contrast from proximal portion to duodenum through the stent. This is best done a day
or two days after stenting.
4. Special issues on biliary stent
#1 Bare stent versus covered stent
There have been several reports comparing stent patency rate between bare stent
and covered stent. Based on these reports, the patency rate may be longer in covered
stent. However, covered stent needs bigger access route and longer landing zone. It
also has higher risk of stent migration and obstructing other branches. Therefore, the
selection should be considered based on not only technical factors, but also the
performance status and life expectancy of the patient. In patients with poor prognosis
of less than a few months, usually there is no difference in clinical outcome between
both stents.
#2 Indication for patients with massive ascites
The risk of bleeding and biliary peritonitis must be considered in biliary stenting
for a patient with massive ascites. The easiest method is performing all biliary
procedures after complete ascites drainage. On the other hand, there is risk of
bleeding and leakage of bile juice caused by keeping percutaneous tubes through
ascites or accidental withdrawal of catheter and/or guidewire. Therefore, if all
procedures and removal of all tubes are completed in one session, and tract
embolization with coils/gelatin sponge were completely performed, biliary stenting can
be carried out without complications (Figure 10)
#3 Stent placement across the papilla of Vater (Figure 11)
Manipulation of guidewire or catheter can cause transient edematous change in
papilla of Vater, resulting in temporary obstruction of contrast flow. This may mimic
obstruction caused by tumour. Thus, the function of papilla of Vater must be observed
14. PTBD/PTGBD, Biliary stent (Shunsuke Sugawara, MD)
carefully prior to guidewire/catheter manipulation in this area. In cases where the
papilla of Vater is involved and obstructed by tumour, stent placement across the
papilla of Vater should be performed. The length of stent protruding into the duodenum
should not be too long because the edge of the stent abutting the intestinal wall may
injure the wall, leading to ulceration and bleeding.
Sometimes, stent placement across the papilla of Vater causes pancreatitis. However,
in most of the case, it disappears with medical treatment.
#4 Combination with balloon dilatation
When the stricture is very tight, pre or post balloon dilatation is very useful.
Balloon dilatation before stenting (Pre-dilatation) is also useful to know the
characteristics of stricture (length, hardness, mobility, etc). Balloon dilatation after
stenting (Post stenting) is useful to achieve the full expansion of the stent and to affix
the stent firmly to the inner wall of the bile duct. When post balloon dilatation is
needed for a stent that has potential of foreshortening (woven stent), the first
dilatation should be performed at the narrowest (not expanded) portion of the stent.
In this manner, the stricture site would be covered by the stent even if the stent has
foreshortened (Figure 12).
Figure 1: Insertion of angiographic sheath
14. PTBD/PTGBD, Biliary stent (Shunsuke Sugawara, MD)
Figure 2: Crossing the stricture
Figure 3: Contrast examination of lower biliary system and intestine
Figure 4: Insertion of stent delivery system beyond the stricture
14. PTBD/PTGBD, Biliary stent (Shunsuke Sugawara, MD)
Figure 5: stent release
Figure 6: placement of safety tube
Figure 7: Parallel insertion of stent delivery systems
14. PTBD/PTGBD, Biliary stent (Shunsuke Sugawara, MD)
Figure 8: Stent release (Parallel formation)
Figure 9: Placement of Safety tubes
Figure 10: Tract embolization
14. PTBD/PTGBD, Biliary stent (Shunsuke Sugawara, MD)
Figure 11: Stent placement crossing the papilla of Vater
Figure 12: Foreshortening of stent with balloon dilatation
14. PTBD/PTGBD, Biliary stent (Shunsuke Sugawara, MD)
References
1) Itoi T, Tsuyuguchi T, Takada T et al. TG13 indications and techniques for biliary
drainage in acute cholangitis (with videos). J Hepatobiliary Pancreat Sci 2013; 20:
71-80.
2) Lee W, Kim GC, Kim JY et al. Ultrasound and fluoroscopy guided percutaneous
transhepatic biliary drainage in patients with nondilated bile ducts. Abdom Imaging
2008; 33: 555-559.
3) Saad WE, Wallace MJ, Wojak JC et al. Quality improvement guidelines for
percutaneous transhepatic cholangiography, biliary drainage, and percutaneous
cholecystostomy. J Vasc Interv Radiol 2010; 21: 789-795.
4) Okamoto K, Suzuki K, Takada T et al. Tokyo Guidelines 2018: flowchart for the
management of acute cholecystitis. J Hepatobiliary Pancreat Sci 2018; 25: 55-72.
5) Mori Y, Itoi T, Baron TH et al. Tokyo Guidelines 2018: management strategies for
gallbladder drainage in patients with acute cholecystitis (with videos). J
Hepatobiliary Pancreat Sci 2018; 25: 87-95.
6) Isayama H, Komatsu Y, Tsujino T et al. A prospective randomised study of
"covered" versus "uncovered" diamond stents for the management of distal
malignant biliary obstruction. Gut 2004; 53: 729-734.
7) Soderlund C, Linder S. Covered metal versus plastic stents for malignant common
bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc
2006; 63: 986-995.
8) Inal M, Akgul E, Aksungur E, Seydaoglu G. Percutaneous placement of biliary
metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar
drainage. J Vasc Interv Radiol 2003; 14: 1409-1416.
9) Brountzos EN, Ptochis N, Panagiotou I et al. A survival analysis of patients with
malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc
Intervent Radiol 2007; 30: 66-73.
10) Rerknimitr R, Kongkam P, Kullavanijaya P. Outcome of self-expandable metallic
stents in low-grade versus advanced hilar obstruction. J Gastroenterol Hepatol
2008; 23: 1695-1701.